Inside the Race to Detect Neurodegenerative Disease Early

0

1. Early detection of neurodegenerative diseases is vital for patient outcomes.

2. Amprion focuses on diagnostics for Alzheimer's, Parkinson's, and Huntington’s diseases.

3. SAAmplify-αSyn assay shows exceptional accuracy in detecting biomarkers.

4. The test can identify active disease years before clinical diagnosis.

5. Precision medicine is emerging as a diagnostic approach.

6. Innovations in AI and biomarker science are shaping future diagnostics.

7. 80 million people worldwide live with neurodegenerative diseases.